课题基金 / 基金详情

INTRACELLULAR INFECTION BY INVASIVE GROUP A STREPTOCOCCI

INTRACELLULAR INFECTION BY INVASIVE GROUP A STREPTOCOCCI
侵袭性 A 型链球菌的细胞内感染
批准号:
2757762
负责人:
PAUL Patrick CLEARY
金额:
$13.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-12-01 至 2002-11-30

项目摘要

项目成果

PAUL Patrick CLEARY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The resurgence of serious group A streptococcal disease which includes sepsis, toxic shock and necrotizing fasciitis has been thoroughly documented. Although other serotypes are associated with these complications, epidemiological data argue that the serotype M1 inv+ subclone was responsible for the increased incidence of toxic shock in the 1990s. Our laboratory was the first to identify the M1 clonal variant that ultimately spread to at least five continents. The overall goal of this project is to understand the role of intracellular invasion of epithelial cells in the persistence and dissemination of highly virulent strains of group A streptococci in human populations. Much of the study will focus on the molecular interactions between M protein-extracellular matrix proteins laminin and fibronectin and the epithelial cell. Experiments will define the role of M1 protein and other bacteriophage and chromosomally encoded proteins in high frequency invasion of human cells. Invasin-agonist functions will be analyzed separate from other streptococcal factors using latex beads and scanning electron microscopy. Finally, in vitro requirements for high frequency invasion will be validated using tonsil organ cultures. These studies may provide an explanation for the failure of penicillin to eradicate streptococci from the oral mucosa of children with recurrent infections.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
T cell immune response to group A streptococci in NALT
  • 批准号:
    6867089
  • 项目类别:
  • 资助金额:
    $29.41万
  • 财政年份:
    2004
  • 负责人:
    PAUL Patrick CLEARY
  • 依托单位:
T cell immune response to group A streptococci in NALT
  • 批准号:
    7154787
  • 项目类别:
  • 资助金额:
    $28.35万
  • 财政年份:
    2004
  • 负责人:
    PAUL Patrick CLEARY
  • 依托单位:
T cell immune response to group A streptococci in NALT
  • 批准号:
    6989110
  • 项目类别:
  • 资助金额:
    $29.2万
  • 财政年份:
    2004
  • 负责人:
    PAUL Patrick CLEARY
  • 依托单位:
T cell immune response to group A streptococci in NALT
  • 批准号:
    7323232
  • 项目类别:
  • 资助金额:
    $27.31万
  • 财政年份:
    2004
  • 负责人:
    PAUL Patrick CLEARY
  • 依托单位:
国内基金
海外基金
影响Streptococcus pyogenes CRISPR/Cas9脱靶的相关因素及其靶向特异性机制研究
  • 批准号:
    31770069
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2017
  • 负责人:
    孙宇辉
  • 依托单位: